Skip to main content

TEVA 7164 (Tolterodine Tartrate Extended-Release 4 mg)

Pill with imprint TEVA 7164 is Blue, Capsule-shape and has been identified as Tolterodine Tartrate Extended-Release 4 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Tolterodine is used in the treatment of urinary incontinence; urinary frequency and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Tolterodine 4 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 7164

Tolterodine tartrate extended-release 4 mg TEVA 7164

Tolterodine Tartrate Extended-Release

TEVA 7164
4 mg
18.00 mm
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
Inactive Ingredients
ethylcellulose (7 mPa.s), hypromellose 2910 (6 mPa.s), ferrosoferric oxide, propylene glycol, shellac, sucrose, corn starch, titanium dioxide, triethyl citrate, FD&C Blue No. 1

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.